• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Amylyx Pharma Nominates Gubra`s AMX0318 as GLP-1RA Candidate

    BUSINESSWIRE

    Amylyx Axes Drug Program for Rare Neurodegenerative Disorder

    BIOSPACE

    Amylyx Reports Positive Long-Term HELIOS Trial Data

    BUSINESSWIRE

    Amylyx Announces Positive Results From Ph 2 Trial with Wolfram Syndrome

    BUSINESSWIRE

    Amylyx Pharmaceuticals Hosts Webcast On Phase 2 HELIOS Study

    BUSINESSWIRE

    Amylyx`s AMX0035 Gets EU Orphan Drug Status For Wolfram Syndrome

    BUSINESSWIRE

    Amylyx stock slips 6% after phase 2 rare disease data drop

    FIERCE BIOTECH

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.